These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 16968989)

  • 1. Gene-based therapy for hypertension--do preclinical data suggest a promising future?
    Puddu GM; Cravero E; Ferrari E; Muscari A; Puddu P
    Cardiology; 2007; 108(1):40-7. PubMed ID: 16968989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisense oligonucleotides strategy in the treatment of hypertension.
    Kagiyama S; Kagiyama T; Phillips MI
    Curr Opin Mol Ther; 2001 Jun; 3(3):258-64. PubMed ID: 11497350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antisense inhibition of the renin-angiotensin system in brain and peripheral organs.
    Mohuczy D; Phillips MI
    Methods; 2000 Nov; 22(3):197-209. PubMed ID: 11071815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antisense inhibition and adeno-associated viral vector delivery for reducing hypertension.
    Phillips MI
    Hypertension; 1997 Jan; 29(1 Pt 2):177-87. PubMed ID: 9039099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antisense therapeutics for hypertension: targeting the renin-angiotensin system.
    Phillips MI; Kimura B
    Methods Mol Med; 2005; 106():51-68. PubMed ID: 15375312
    [No Abstract]   [Full Text] [Related]  

  • 6. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisense approaches to cancer gene therapy.
    Mercola D; Cohen JS
    Cancer Gene Ther; 1995 Mar; 2(1):47-59. PubMed ID: 7621254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy for hypertension: antisense inhibition with adeno-associated viral vector delivery targeting angiotensin II type 1-receptor messenger ribonucleic acid.
    Phillips MI
    Am J Cardiol; 1998 Nov; 82(10A):60S-62S. PubMed ID: 9860363
    [No Abstract]   [Full Text] [Related]  

  • 9. Angiotensin-converting enzyme 2 as a novel target for gene therapy for hypertension.
    Katovich MJ; Grobe JL; Huentelman M; Raizada MK
    Exp Physiol; 2005 May; 90(3):299-305. PubMed ID: 15640278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antisense inhibition: oligonucleotides, ribozymes, and siRNAs.
    Zhang YC; Taylor MM; Samson WK; Phillips MI
    Methods Mol Med; 2005; 106():11-34. PubMed ID: 15375310
    [No Abstract]   [Full Text] [Related]  

  • 11. Attenuation of hypertension by systemic delivery of retroviral vector containing type I angiotensin II receptor antisense cDNA.
    Reaves PY; Wang HW; Katovich MJ; Gelband CH; Raizada MK
    Methods; 2000 Nov; 22(3):211-8. PubMed ID: 11071816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy for hypertension: antisense inhibition of the renin-angiotensin system.
    Phillips MI; Kimura B
    Methods Mol Med; 2005; 108():363-79. PubMed ID: 16028695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of gene expression by antisense and antigene oligodeoxynucleotides and small interfering RNA.
    Mahato RI; Cheng K; Guntaka RV
    Expert Opin Drug Deliv; 2005 Jan; 2(1):3-28. PubMed ID: 16296732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical study on gene therapy of cervical carcinoma using adeno-associated virus vectors.
    Kunke D; Grimm D; Denger S; Kreuzer J; Delius H; Komitowski D; Kleinschmidt JA
    Cancer Gene Ther; 2000 May; 7(5):766-77. PubMed ID: 10830724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time course of inhibition of hypertension by antisense oligonucleotides targeted to AT1 angiotensin receptor mRNA in spontaneously hypertensive rats.
    Gyurko R; Tran D; Phillips MI
    Am J Hypertens; 1997 May; 10(5 Pt 2):56S-62S. PubMed ID: 9160782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gene therapy].
    Rodríguez-Fragoso L
    Rev Invest Clin; 1997; 49(5):397-409. PubMed ID: 9527700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The future of hypertension therapy: sense, antisense, or nonsense?
    Pachori AS; Huentelman MJ; Francis SC; Gelband CH; Katovich MJ; Raizada MK
    Hypertension; 2001 Feb; 37(2 Pt 2):357-64. PubMed ID: 11230300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleic acid-based modulation of cardiac gene expression for the treatment of cardiac diseases. Approaches and perspectives.
    Poller W; Fechner H; Kurreck J; Pauschinger M; Kühl U; Erdmann VA; Lamers JM; Schultheiss HP
    Z Kardiol; 2004 Mar; 93(3):171-93. PubMed ID: 15024585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antisense oligonucleotides targeting angiotensinogen: insights from animal studies.
    Wu CH; Wang Y; Ma M; Mullick AE; Crooke RM; Graham MJ; Daugherty A; Lu HS
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30530571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of in vivo gene transfer methods towards future gene therapy].
    Kaneda Y; Morishita R
    Rinsho Byori; 1997 Feb; 45(2):99-105. PubMed ID: 9121006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.